Health insurer’s purchase of Express Scripts is looking like even more of a blunder……..
By Charley Grant
Feb. 1, 2019
Cigna has more work to do if it wants to convince investors that its $54 billion deal was a good idea.
The health insurer, which closed its acquisition of the pharmacy-benefits manager Express Scripts in December, unveiled its 2019 profit outlook Friday morning.
Cigna expects adjusted earnings of $16 to $16.50 a share this year. That implies…
TO READ THE FULL STORY
